Brief: Black Diamond Therapeutics Q3 basic EPS USD -0.45
Nov 6 (Reuters) - Black Diamond Therapeutics Q3 net income USD -23.007 million. * Q3 basic EPS USD -0.45 * Q3 operating expenses USD 24.012 million * Q3 income from operations USD -24.012 million